| Re-discovery of pyrimidine salvage as target in cancer therapy M Walter, P Herr Cells 11 (4), 739, 2022 | 45 | 2022 |
| Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems D Luethi, KE Kolaczynska, M Walter, M Suzuki, KC Rice, BE Blough, ... Journal of Psychopharmacology 33 (7), 831-841, 2019 | 37 | 2019 |
| Para-Halogenation Affects Monoamine Transporter Inhibition Properties and Hepatocellular Toxicity of Amphetamines and Methcathinones D Luethi, M Walter, X Zhou, D Rudin, S Krähenbühl, ME Liechti Frontiers in pharmacology 10, 438, 2019 | 32 | 2019 |
| Structure-based identification and biological characterization of new NAPRT inhibitors J Franco, F Piacente, M Walter, S Fratta, M Ghanem, A Benzi, I Caffa, ... Pharmaceuticals 15 (7), 855, 2022 | 14 | 2022 |
| NUDT22 promotes cancer growth through pyrimidine salvage M Walter, F Mayr, BMF Hanna, V Cookson, O Mortusewicz, T Helleday, ... Oncogene 42 (16), 1282-1293, 2023 | 3 | 2023 |
| Exploitation of the UDP-glucose hydrolase NUDT22 as novel target in cancer therapy M Walter University of Sheffield, 2022 | 1 | 2022 |
| Homologous recombination promotes non-immunogenic mitotic cell death upon DNA damage R Szmyd, S Casolin, L French, AG Manjón, M Walter, L Cavalli, ... Nature Cell Biology, 1-14, 2025 | | 2025 |
| NUDT22 promotes cancer growth through pyrimidine salvage and the TCA cycle M Walter, F Mayr, BMF Hanna, V Cookson, O Mortusewicz, T Helleday, ... | | 2022 |
| Development of small molecule NUDT22 inhibitors for uses in cancer M Walter, E Homan, T Koolmeister, I Almlöf, O Mortusewicz, T Helleday, ... Medical Sciences Forum 3 (1), 1, 2021 | | 2021 |
